Jupiter Neurosciences, Inc.
JUNS
$0.64
$0.00761.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -48.40% | -- | -- | -- | -- |
| Gross Profit | 48.40% | -- | -- | -- | -- |
| SG&A Expenses | -10.93% | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.20% | -- | -- | -- | -- |
| Operating Income | 20.20% | -- | -- | -- | -- |
| Income Before Tax | 49.00% | -- | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 49.00% | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.00% | -- | -- | -- | -- |
| EBIT | 20.20% | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 55.96% | -- | -- | -- | -- |
| Normalized Basic EPS | 24.51% | -- | -- | -- | -- |
| EPS Diluted | 56.21% | -- | -- | -- | -- |
| Normalized Diluted EPS | 26.14% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 10.57% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 13.46% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |